AI
KNSA icon

Atom Investors’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Atom Investors’s Portfolio KNSA Stock Details KNSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-48,952
Closed -$865K – 339
2020
Q4 		$865K Sell
48,952
-141,986
-74% -$2.49M 0.09% 201
2020
Q3 		$2.92M Sell
190,938
-20,506
-10% -$385K 0.28% 88
2020
Q2 		$5.39M Buy
211,444
+18,199
+9% +$380K 0.35% 54
2020
Q1 		$2.99M Buy
+193,245
New +$3.02M 0.26% 92

Other funds holding KNSA

HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Atom Investors's KNSA Position: Q1 2021 in Review

Atom Investors sold out of Kiniksa Pharmaceuticals (KNSA) in Q1 2021, closing a stake of 48,952 shares — an estimated $865K sold.

Atom Investors first reported a position in KNSA in Q1 2020 and held it in 4 quarters. The position peaked at $5.39M in Q2 2020. 105 funds tracked by Wall St. Rank hold KNSA as of Q1 2021.

  • Atom Investors reported no remaining Kiniksa Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
  • Atom Investors sold 48,952 Kiniksa Pharmaceuticals shares in Q1 2021, an estimated $865K.
  • Atom Investors first reported a position in Kiniksa Pharmaceuticals in Q1 2020 and held it in 4 quarters.
  • Atom Investors's Kiniksa Pharmaceuticals position peaked at $5.39M in Q2 2020.
  • 105 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q1 2021.

Based on Atom Investors's 13F filing for Q1 2021, filed 17 May 2021.